SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 13F-NT - Quarterly report filed by institutional managers, Notice:
SEC Accession No. 0000950123-24-001896
Filing Date
2024-02-13
Accepted
2024-02-13 16:30:08
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-02-13

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 13F-NT  
1 primary_doc.xml 13F-NT 2978
  Complete submission text file 0000950123-24-001896.txt   4067
Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 6175162000
Bain Capital Life Sciences Opportunities III, LP (Filer) CIK: 0001950105 (see all company filings)

IRS No.: 871325992 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 13F-NT | Act: 34 | File No.: 028-22966 | Film No.: 24626515